13.28 (-%)
As of Nov 01, 2024
Source:
Zymeworks is a biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks’ mission is to make a meaningful difference for people impacted by difficult-to-treat cancers and other serious diseases. Zymeworks’ complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates.
Country | United States |
Headquarters | middletown, delaware |
Phone Number | 206-337-1030 |
Industry | |
CEO | Kenneth Galbraith |
Website | www.zymeworks.com |